Premature closure of a phase II study of bendamustine, mitoxantrone and rituximab for patients with untreated high-risk follicular lymphoma due to severe haematological and infectious toxicity

Chan Cheah, LJ Nastoupil, P McLaughlin, MA Fanale, SS Neelapu, LE Fayad, FB Hagemeister, NH Fowler

    Research output: Contribution to journalLetter

    5 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)531-545
    Number of pages15
    JournalBritish Journal of Haematology
    Volume175
    Issue number3
    Publication statusPublished - 2016

    Cite this